Clinical Trial Update: Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tacrolimus for preventing rejection in African-American kidney transplant recipients; the study is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease
• Rejection of Kidney Transplant

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Kidney Disease, End-Stage, Donor Specific Antibodies | Phase 4 | Status: ACTIVE_NOT_RECRUITING